
Keywords: Aldose reductase; Enzyme inhibitors; Anti-inflammatory agents; Molecular modelling; 5-Arylidene-4-thiazolidinone derivatives; 5-(carbamoylmethoxy)benzylidene-2-oxo/thioxo-4-thiazolidinone derivatives; AGEs; advanced glycation-end products; AR; aldose redu